Since 1992, British-made CACI International has been a global leader in advanced beauty technology, revolutionising the aesthetics industry with innovative, non-invasive treatments. Setting the standard for clinical excellence and innovation, CACI has pioneered anti-ageing solutions, skin rejuvenation treatments and results-driven skin treatments for over three decades.

CACI is expanding into the advanced medical aesthetics market with the launch of a revolutionary multi-technology platform, CACI Rejuva Med. This state-of-the-art aesthetic system integrates five clinically proven, precision-engineered technologies to deliver targeted, measurable, and transformative skin rejuvenation results. Designed for medical and advanced aesthetic practices, CACI Rejuva Med offers powerful, non-invasive aesthetic treatments in a single, compact, high-performance system.

The CACI Difference

At the core of the CACI Rejuva Med system is advanced multi-technology integration including CACI's iconic microcurrent, enabling clinics and medical aesthetic practices to deliver a wide range of high-performance, non-invasive aesthetic treatments from one innovative platform. This unique, space-efficient system maximises clinic floor space, treatment versatility, return on investment, and client outcomes.
As an advanced medical grade device, Rejuva Med supports long-term skin integrity and rejuvenation with every treatment. The system is expertly engineered to stimulate collagen and elastin production, enhance circulation, correct uneven skin tone and texture, and accelerate cellular regeneration and repair. Through a combination of muscle toning, skin tightening, and needle-free transdermal delivery, Rejuva Med delivers clinically proven, transformative aesthetic results, with minimal downtime.